Age, years, mean (SD) |
64.1 (10.1) |
58.6 (9.7) |
0.06 |
64.8 (8.2) |
59.1 (8.8) |
0.02 |
Males, % |
76.5 |
62.2 |
0.30 |
77.3 |
56.8 |
0.11 |
Caucasian race, % |
82.4 |
91.7 |
0.37 |
85.7 |
83.8 |
0.99 |
Married, % |
17.6 |
48.6 |
0.03 |
54.5 |
45.9 |
0.52 |
Lives alone, % |
47.1 |
48.6 |
0.91 |
31.8 |
43.2 |
0.38 |
Alcohol use within 6 months, % |
17.6 |
16.2 |
0.99 |
4.5 |
27.0 |
0.04 |
Substance use within 6 months, % |
0 |
10.8 |
0.30 |
4.5 |
5.4 |
0.99 |
Psychiatric comorbidity, % |
11.8 |
17.1 |
0.99 |
4.5 |
8.6 |
0.99 |
Acute kidney injury, % |
70.6 |
73.0 |
0.99 |
54.5 |
59.5 |
0.71 |
Charlson comorbidity index, mean (SD) |
4.8 (2.6) |
3.9 (2.6) |
0.27 |
5.5 (2.0) |
4.6 (3.1) |
0.25 |
Insurance, % |
|
|
0.31 |
|
|
0.16 |
Medicare |
52.9 |
32.4 |
|
54.5 |
40.5 |
|
Medicaid |
11.8 |
27.0 |
|
4.5 |
21.6 |
|
Private |
23.5 |
35.1 |
|
40.9 |
29.7 |
|
Uninsured |
11.8 |
5.4 |
|
0 |
8.1 |
|
Body mass index, kg/m2, mean (SD) |
27.5 (6.4) |
32.1 (7.7) |
0.07 |
30.6 (9.3) |
27.7 (5.9) |
0.19 |
Liver disease etiology, % |
|
|
0.95 |
|
|
0.71 |
Alcohol |
35.3 |
29.7 |
|
27.3 |
29.7 |
|
Viral |
17.6 |
21.6 |
|
22.7 |
29.7 |
|
Alcohol+Viral |
11.8 |
13.5 |
|
9.1 |
16.2 |
|
NASH/cryptogenic |
17.6 |
24.3 |
|
27.3 |
18.9 |
|
Other |
17.6 |
10.8 |
|
13.6 |
5.4 |
|
Ascites, % |
100 |
97.3 |
0.99 |
95.5 |
94.6 |
0.99 |
Hepatic hydrothorax, % |
17.6 |
10.8 |
0.67 |
18.2 |
13.5 |
0.72 |
Hepatic encephalopathy, % |
70.6 |
83.8 |
0.29 |
68.2 |
73.0 |
0.69 |
Portal vein thrombosis, % |
17.6 |
5.6 |
0.31 |
36.4 |
13.9 |
0.06 |
Hepatocellular carcinoma, % |
23.5 |
21.6 |
0.99 |
40.9 |
29.7 |
0.38 |
Outside Milan criteria |
100 |
25.0 |
0.06 |
44.4 |
36.4 |
0.99 |
MELD-Na, mean (SD) |
27.4 (8.1) |
26.7 (6.4) |
0.74 |
24.7 (7.9) |
25.4 (7.4) |
0.74 |
Child–Pugh score, mean (SD) |
11.4 (2.0) |
11.7 (2.0) |
0.56 |
11.4 (1.8) |
11.1 (2.2) |
0.67 |
Child–Pugh class, % |
|
|
0.99 |
|
|
0.30 |
A |
0 |
0 |
|
0 |
0 |
|
B |
11.8 |
13.5 |
|
9.5 |
22.2 |
|
C |
88.2 |
86.5 |
|
90.5 |
77.8 |
|
Transplant status, % |
|
|
0.60 |
|
|
0.74 |
Not evaluated |
52.9 |
40.5 |
|
40.9 |
48.6 |
|
Evaluated, but not listed |
47.1 |
54.1 |
|
59.1 |
48.6 |
|
Listed |
0 |
5.4 |
|
0 |
2.7 |
|